U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


MOYES JAY M (0001191062)
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
SERA PROGNOSTICS, INC. 0001534969 2021-07-14 officer: Chief Financial Officer
PREDICTIVE TECHNOLOGY GROUP, INC. 0001382943 2019-02-28 director
SONUS PHARMACEUTICALS INC
Current Name:ACHIEVE LIFE SCIENCES, INC.		 0000949858 2017-08-01 director
CLICKNSETTLE COM INC
Current Name:BioCardia, Inc.		 0000925741 2016-10-24 director
AMEDICA Corp
Current Name:Sintx Technologies, Inc.		 0001269026 2014-02-12 director, officer: Chief Fnancial Officer
PUMA BIOTECHNOLOGY, INC. 0001401667 2012-04-27 director
OSIRIS THERAPEUTICS, INC. 0001360886 2006-08-03 director
MYRIAD GENETICS INC 0000899923 2003-02-13 officer: Chief Financial Officer


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-10-11   BioCardia, Inc. 4 A-Award --D 829.0000 3573.0000 1 0000925741 Stock Option (right to buy)
A 2024-06-18   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 27000.0000 48322.0000 1 0001401667 Common Stock
D 2024-06-13   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 22000.0000 21322.0000 1 0001401667 Common Stock
A 2023-10-18   BioCardia, Inc. 4 A-Award --D 12434.0000 41233.0000 1 0000925741 Stock Option (right to buy)
A 2023-06-13   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 27000.0000 43322.0000 2 0001401667 Common Stock
D 2023-06-13   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 22000.0000 16322.0000 1 0001401667 Common Stock
A 2023-03-06   SERA PROGNOSTICS, INC. 4 A-Award --D 51800.0000 51800.0000 2 0001534969 Stock Option (right to buy)
A 2023-03-06   SERA PROGNOSTICS, INC. 4 A-Award --D 32800.0000 35630.0000 1 0001534969 Class A Common Stock
D 2022-06-16   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 22858.0000 38322.0000 1 0001401667 Common Stock
A 2022-06-14   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 27000.0000 61180.0000 1 0001401667 Common Stock
A 2022-06-10   BioCardia, Inc. 4 A-Award --D 12434.0000 28789.0000 1 0000925741 Stock Option (right to buy)
A 2022-05-31   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 4400.0000 4400.0000 1 0000949858 Stock Option (right to buy)
A 2022-03-23   SERA PROGNOSTICS, INC. 4 A-Award --D 168275.0000 168275.0000 1 0001534969 Stock Option (right to buy)
D 2021-07-19   SERA PROGNOSTICS, INC. 4 C-Conversion --D 375.0000 0.0000 4 0001534969 Series B-1 Preferred Stock
D 2021-07-19   SERA PROGNOSTICS, INC. 4 C-Conversion --D 2455.0000 0.0000 3 0001534969 Series A-2 Preferred Stock
A 2021-07-19   SERA PROGNOSTICS, INC. 4 C-Conversion --D 375.0000 2830.0000 2 0001534969 Class A Common Stock
A 2021-07-19   SERA PROGNOSTICS, INC. 4 C-Conversion --D 2455.0000 2455.0000 1 0001534969 Class A Common Stock
A 2021-06-15   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 27858.0000 34180.0000 1 0001401667 Common Stock
A 2021-06-15   BioCardia, Inc. 4 A-Award --D 12434.0000 16355.0000 1 0000925741 Stock Option (right to buy)
D 2021-06-10   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 25248.0000 6322.0000 1 0001401667 Common Stock
A 2021-05-11   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 3750.0000 3750.0000 1 0000949858 Stock Option (right to buy)
A 2021-03-31   BioCardia, Inc. 4 A-Award --D 3456.0000 54267.0000 1 0000925741 Common Stock
A 2020-12-31   BioCardia, Inc. 4 A-Award --D 3750.0000 50811.0000 2 0000925741 Common Stock
A 2020-12-31   BioCardia, Inc. 4 A-Award --D 2800.0000 47061.0000 1 0000925741 Common Stock
A 2020-09-30   BioCardia, Inc. 4 A-Award --D 3750.0000 44261.0000 1 0000925741 Common Stock
D 2020-09-16   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 9703.0000 31570.0000 1 0001401667 COMMON STOCK
A 2020-06-30   BioCardia, Inc. 4 A-Award --D 3750.0000 40511.0000 1 0000925741 Common Stock
D 2020-06-16   PUMA BIOTECHNOLOGY, INC. 4 S-Sale --D 9720.0000 41273.0000 1 0001401667 COMMON STOCK
A 2020-06-09   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 25748.0000 50993.0000 1 0001401667 COMMON STOCK
A 2020-05-12   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 22000.0000 22000.0000 1 0000949858 Stock Option (right to buy)
A 2020-05-08   BioCardia, Inc. 4 A-Award --D 8800.0000 36761.0000 1 0000925741 Common Stock
A 2020-04-30   BioCardia, Inc. 4 A-Award --D 3750.0000 27961.0000 2 0000925741 Common Stock
A 2020-04-30   BioCardia, Inc. 4 A-Award --D 20250.0000 24211.0000 1 0000925741 Common Stock
D 2019-07-26   BioCardia, Inc. 4 M-Exempt --D 3594.0000 0.0000 2 0000925741 Restricted Stock Units
A 2019-07-26   BioCardia, Inc. 4 M-Exempt --D 3594.0000 3961.0000 1 0000925741 Common Stock
A 2019-06-10   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 19423.0000 25245.0000 1 0001401667 COMMON STOCK
A 2019-05-14   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 7000.0000 7000.0000 1 0000949858 Stock Option (right to buy)
A 2018-09-20   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 12000.0000 12000.0000 1 0000949858 Stock Option (right to buy)
A 2018-07-26   BioCardia, Inc. 4 A-Award --D 32353.0000 32353.0000 1 0000925741 Restricted Stock Units
A 2018-06-12   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 5822.0000 5822.0000 1 0001401667 COMMON STOCK
A 2017-08-01   ACHIEVE LIFE SCIENCES, INC. 4/A A-Award --D 16400.0000 16400.0000 1 0000949858 Stock Option (right to buy)
A 2017-08-01   ACHIEVE LIFE SCIENCES, INC. 4 A-Award --D 16400.0000 16400.0000 1 0000949858 Stock Option (right to buy)
A 2017-06-15   BioCardia, Inc. 4 A-Award --D 156583.0000 156583.0000 1 0000925741 Director Stock Option (right to buy)
A 2017-06-12   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 7604.0000 7604.0000 1 0001401667 Stock Option (Right to Buy)
A 2017-01-13   BioCardia, Inc. 4 A-Award --D 267000.0000 267000.0000 1 0000925741 Director Stock Option (right to buy)
A 2016-11-14   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 10000.0000 10000.0000 1 0001401667 Stock Option (Right to Buy)
A 2015-12-16   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 10000.0000 10000.0000 1 0001401667 Stock Option (Right to Buy)
A 2015-08-26   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 20000.0000 20000.0000 1 0001401667 Stock Option (Right to Buy)
A 2014-12-15   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 10000.0000 10000.0000 1 0001401667 Stock Option (Right to Buy)
D 2014-02-19   AMEDICA Corp 4 C-Conversion --I 25000.0000 0.0000 4 0001269026 Series F Preferred Stock
D 2014-02-19   AMEDICA Corp 4 C-Conversion --D 39556.0000 0.0000 3 0001269026 Series A Preferred Stock
A 2014-02-19   AMEDICA Corp 4 C-Conversion --I 6250.0000 6250.0000 2 0001269026 Common Stock
A 2014-02-19   AMEDICA Corp 4 C-Conversion --D 1534.0000 60312.0000 1 0001269026 Common Stock
A 2013-12-19   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 10000.0000 10000.0000 1 0001401667 Stock Option (Right to Buy)
A 2013-02-12   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 5000.0000 21500.0000 1 0001360886 Common Stock
A 2013-02-06   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 5000.0000 26500.0000 1 0001360886 Common Stock
A 2012-10-18   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 20000.0000 20000.0000 1 0001401667 STOCK OPTION (RIGHT TO BUY)
A 2012-10-18   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 20000.0000 20000.0000 2 0001401667 STOCK OPTION (RIGHT TO BUY)
A 2012-04-27   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 10000.0000 10000.0000 2 0001401667 STOCK OPTION (RIGHT TO BUY)
A 2012-04-27   PUMA BIOTECHNOLOGY, INC. 4 A-Award --D 30000.0000 30000.0000 1 0001401667 STOCK OPTION (RIGHT TO BUY)
A 2012-03-23   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 3000.0000 16500.0000 1 0001360886 Common Stock
A 2011-02-14   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 3000.0000 13500.0000 1 0001360886 Common Stock
A 2010-05-27   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 3000.0000 10500.0000 1 0001360886 Common Stock
A 2009-02-23   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 3000.0000 7500.0000 1 0001360886 Common Stock
A 2008-02-04   OSIRIS THERAPEUTICS, INC. 4 A-Award --D 3000.0000 4500.0000 1 0001360886 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 172.0000 25282.0000 18 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 344.0000 25626.0000 3 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 90.0000 25282.0000 2 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 90.0000 25372.0000 1 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 64.0000 25282.0000 30 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 64.0000 25346.0000 29 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 258.0000 25282.0000 28 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 258.0000 25540.0000 27 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 86.0000 25282.0000 26 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 86.0000 25368.0000 25 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 774.0000 25282.0000 24 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 774.0000 26056.0000 23 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 860.0000 25282.0000 22 0000899923 Common Stock
A 2007-10-15   MYRIAD GENETICS INC 4 M-Exempt --D 86.0000 25368.0000 13 0000899923 Common Stock
D 2007-10-15   MYRIAD GENETICS INC 4 S-Sale --D 344.0000 25282.0000 12 0000899923 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016